British Journal of Cancer · 2001 · 251 citations · 27 references
MedicineOncologyCancer EpidemiologyEpidemiologic MethodsEpidemiologyCancer IncidenceCancer RiskMalignant NeoplasmsTemporal Trends In CancerThyroid CancerAge-adjusted Cancer RatesAge-specific Cancer IncidenceAge-specific Cancer PatternsAge-specific Incidence PatternsBirth Cohort EffectsCancer Time Trends By Birth CohortCancer Trends By AgeYoung Women
We examined time trends in thyroid cancer incidence in Canada by age, time period and birth cohort between 1970 and 1996. Age-specific incidence rates by time period and birth cohort were calculated and age-period-cohort modelling used to estimate effects underlying the observed trends. Overall age-adjusted incidence rates of thyroid cancer doubled, from 3.3 and 1.1 per 100 000 in 1970-72 to 6.8 and 2.2 per 100 000 in 1994-96, among females and males respectively. Almost all the increase between 1970-72 and 1994-96 was due to papillary carcinoma of the thyroid. Age, birth cohort and period effects significantly improved the fit of the model for females, while age and birth cohort effects were significant determinants of the incidence among males. There were significant differences in the patterns/curvature for age, period and birth cohort effects between women and men. Our results suggest that the increases in thyroid cancer incidence in Canada may be associated with more intensive diagnostic activities and change in radiation exposure in childhood and adolescence. Temporal changes in reproductive factors among young women may explain some of the gender differences observed.
27
Cancer Incidence in Five Continents
Richard Doll, C. S. Muir, John A. H. Waterhouse · 1970 · 8.5K citations
Trends in Cancer Incidence, Survival and Mortality
Jacques Estève, Michel P. Coleman · 2009 · 765 citations
Medicine, Oncology, Cancer Control +16
A Population-Based Case-Control Study of Thyroid Cancer
Elaine Ron, Ruth A. Kleinerman, J. D. Boice et al. · JNCI Journal of the National Cancer Institute · 1987 · 345 citations
Medicine, Oncology, Cancer Control +16